|
2018-05-08
|
Impact of 18F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy
published
| article-journal
doi:10.1038/s41598-018-25350-7
|
|
2018
|
Treatment of glioblastoma in adults
published
| article-journal
doi:10.1177/1756286418790452
|
|
2018-06-26
|
New glioblastoma heterogeneity atlas — a shared resource
published
| article-journal
doi:10.1038/s41582-018-0038-3
|
|
2018-04-26
|
Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomas
published
| article-journal
doi:10.1002/cncr.31371
|
|
2018-07-09
|
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
published
| article-journal
doi:10.1038/s41591-018-0095-6
|
|
2018-08-02
|
Identification of tumor antigens among the HLA peptidomes of Glioblastoma tumors and plasma
published
| article-journal
doi:10.1074/mcp.ra118.000792
|
|
2019-11-12
|
Emerging intersections between neuroscience and glioma biology
published
| article-journal
doi:10.1038/s41593-019-0540-y
|
|
2020-02-18
|
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
published
| article-journal
doi:10.1038/s41467-020-14642-0
|
|
2019-06-13
|
The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials
published
| article-journal
doi:10.1016/j.ejca.2019.05.012
|
|
2020-06-07
|
Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients
published
| article-journal
| CC-BY-NC
doi:10.1093/nop/npaa033
|
|
2020-10-24
|
Adult Precision Medicine: Learning from the Past to Enhance the Future
published
| article-journal
doi:10.1093/noajnl/vdaa145
|
|
2021-08-24
|
MEOX2 homeobox gene promotes growth of malignant gliomas
unknown status
| post
doi:10.1101/2021.08.24.457477
|
|
2021-09-28
|
Comparative evaluation of T cell receptors in experimental glioma-draining lymph nodes
published
| article-journal
doi:10.1093/noajnl/vdab147
|
|
2021-07-05
|
Preventive effect of sensorimotor exercise and resistance training on chemotherapy-induced peripheral neuropathy: a randomised-controlled trial
published
| article-journal
| CC-BY
doi:10.1038/s41416-021-01471-1
|
|
2021-07-07
|
A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma
published
| article-journal
doi:10.1093/neuonc/noab158
|
|
2020-12-08
|
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
published
| article-journal
| CC-BY
doi:10.1038/s41571-020-00447-z
|
|
2021-10-21
|
Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
published
| article-journal
doi:10.1093/neuonc/noab243
|
|
2020-12-22
|
Identification and characterization of cancer cells that initiate metastases to the brain and other organs
published
| article-journal
doi:10.1158/1541-7786.mcr-20-0863
|
|
2022-06-13
|
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trial
published
| article-journal
doi:10.1186/s12885-022-09720-z
|
|
2022-07-29
|
DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas
published
| article-journal
doi:10.1038/s41467-022-31827-x
|
|
2022-05-27
|
Gender disparity regarding work-life balance satisfaction among German neuro-oncologists: a YoungNOA survey
published
| article-journal
doi:10.1093/neuonc/noac114
|
|
2022-08-31
|
T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cells
published
| article-journal
doi:10.1093/noajnl/vdac140
|
|
2022-04-25
|
MEOX2 homeobox gene promotes growth of malignant gliomas
published
| article-journal
doi:10.1093/neuonc/noac110
|
|
2022-12-05
|
Federated learning enables big data for rare cancer boundary detection
published
| article-journal
doi:10.1038/s41467-022-33407-5
|
|
2018-10-01
|
Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib
published
| article-journal
doi:10.1158/1078-0432.ccr-18-1580
|
|
2019-10-25
|
Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecology
published
| article-journal
doi:10.1038/s41467-019-12776-4
|
|
2020-02-07
|
Not yet another negative trial - ReACTing on recent glioblastoma trials!
published
| article-journal
doi:10.1158/1078-0432.ccr-19-4032
|
|
2020-07-10
|
Tumor cell plasticity, heterogeneity and resistance in
crucial microenvironmental niches in glioma
unknown status
| post
| CC-BY
doi:10.21203/rs.3.rs-39208/v1
|
|
2020-09-29
|
Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes
published
| article-journal
| CC-BY
doi:10.1002/cam4.3447
|
|
2020-10-29
|
Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality adjusted survival effect sizes (QASES) and Joint Modeling (JM)
published
| article-journal
doi:10.1093/noajnl/vdaa147
|
|
2021-02-12
|
Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma
published
| article-journal
| CC-BY
doi:10.1038/s41467-021-21117-3
|
|
2021-03-31
|
Primary CNS lymphoma after CLIPPERS: a case series
published
| article-journal
doi:10.1136/jnnp-2020-325759
|
|
2021-10-15
|
Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG03.01) randomized clinical trial
published
| article-journal
doi:10.1093/noajnl/vdab153
|
|
2021-11-17
|
Spatial Probabilistic Mapping of Metabolite Ensembles in Mass Spectrometry Imaging
unknown status
| post
| CC-BY
doi:10.21203/rs.3.rs-1058357/v1
|
|
2021-10-07
|
Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated
published
| article-journal
doi:10.1200/jco.21.00784
|
|
2021-05-24
|
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas
published
| article-journal
| CC-BY
doi:10.1038/s43018-021-00201-z
|
|
2022-03-23
|
Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
published
| article-journal
| CC-BY
doi:10.1038/s41571-022-00623-3
|
|
2021-01-21
|
Sarcoma classification by DNA methylation profiling
published
| article-journal
| CC-BY
doi:10.1038/s41467-020-20603-4
|
|
2022-03-11
|
Temozolomide and radiotherapy versus radiotherapy alone in patients with glioblastoma, IDH-wildtype: post-hoc analysis of the EORTC randomized phase 3 CATNON trial
published
| article-journal
doi:10.1158/1078-0432.ccr-21-4283
|
|
2022-05-24
|
Deep Learning Super-resolution MR Spectroscopic Imaging of Brain Metabolism and Mutant IDH Glioma
published
| article-journal
doi:10.1093/noajnl/vdac071
|
|
2022-08-23
|
Automated detection and quantification of brain metastases on clinical MRI data using artificial neural networks
published
| article-journal
doi:10.1093/noajnl/vdac138
|
|
2022-04-11
|
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period
published
| article-journal
doi:10.1093/neuonc/noac097
|
|
2022-12-14
|
Autonomous rhythmic activity in glioma networks drives brain tumour growth
published
| article-journal
doi:10.1038/s41586-022-05520-4
|
|
2022-05-24
|
Dysfunctional dendritic cells limit antigen-specific T cell response in glioma
published
| article-journal
doi:10.1093/neuonc/noac138
|
|
2018
|
Associations of anticoagulant use with outcome in newly diagnosed glioblastoma
published
| article-journal
doi:10.1016/j.ejca.2018.06.029
|
|
2019-07-11
|
Tunneling nanotube‐like structures in brain tumors
published
| article-journal
doi:10.1002/cnr2.1181
|
|
2019-05-09
|
Repeatability and reproducibility of relative cerebral blood volume measurement of recurrent glioma in a multicentre trial setting
published
| article-journal
doi:10.1016/j.ejca.2019.03.007
|
|
2019-11-28
|
cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma
published
| article-journal
doi:10.1007/s11060-019-03348-z
|
|
2020-07-28
|
Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial
published
| article-journal
doi:10.1148/radiol.2020200978
|
|
2020-12-03
|
Local blood coagulation drives cancer cell arrest and brain metastasis in a mouse model
published
| article-journal
doi:10.1182/blood.2020005710
|
|
2020-11-01
|
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR
published
| article-journal
doi:10.1093/neuonc/noaa251
|
|
2021-02-23
|
Phase I assessment of safety and therapeutic activity of BAY1436032 in patients with IDH1-mutant solid tumors
published
| article-journal
doi:10.1158/1078-0432.ccr-20-4256
|
|
2020-12-24
|
Unique challenges for glioblastoma immunotherapy - Discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology
published
| article-journal
doi:10.1093/neuonc/noaa277
|
|
2021-02-23
|
Phase I assessment of safety and therapeutic activity of BAY1436032 in patients with IDH1-mutant solid tumors
published
| article-journal
doi:10.1158/1078-0432.ccr-20-4256
|
|
2021-03-24
|
A vaccine targeting mutant IDH1 in newly diagnosed glioma
published
| article-journal
| CC-BY
doi:10.1038/s41586-021-03363-z
|
|
2022-01-27
|
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial
published
| unknown type
doi:10.1093/noajnl/vdac011
|
|
2022-02-21
|
Patient Pathways During Acute in-Hospital Stroke Treatment: A Qualitative Multi-Method Study
published
| article-journal
doi:10.5334/ijic.5657
|
|
2022-01-01
|
Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma
published
| article-journal
| CC-BY
doi:10.1093/noajnl/vdac051
|
|
2022-05-10
|
Lung toxicity of CCNU in the treatment of progressive gliomas
published
| article-journal
doi:10.1093/noajnl/vdac068
|
|
2022-03-13
|
Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma: evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101
published
| article-journal
doi:10.1093/nop/npac022
|
|
2022-03-21
|
Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma
published
| article-journal
doi:10.1093/neuonc/noac070
|
|
2019-01-24
|
Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche
published
| article-journal
doi:10.1172/jci.insight.123837
|
|
2022-05-03
|
HIP1R and Vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma
published
| article-journal
doi:10.1093/neuonc/noac111
|
|
2021-11-15
|
T cell receptor therapy targeting mutant capicua transcriptional repressor in experimental gliomas
published
| article-journal
doi:10.1158/1078-0432.ccr-21-1881
|
|
2023-04-01
|
Spatial probabilistic mapping of metabolite ensembles in mass spectrometry imaging
published
| article-journal
doi:10.1038/s41467-023-37394-z
|
|
2023-01-07
|
Objective response rate (ORR) targets for recurrent glioblastoma clinical trials based on the historic association between ORR and median overall survival
published
| article-journal
doi:10.1093/neuonc/noad002
|
|
2023-09-21
|
Effect of Individualized Versus Standardized Blood Pressure Management During Endovascular Stroke Treatment on Clinical Outcome: A Randomized Clinical Trial
published
| article-journal
doi:10.1161/strokeaha.123.044062
|
|
2023-07-26
|
Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial
published
| article-journal
doi:10.1158/1078-0432.ccr-23-0926
|
|
2023-09-21
|
A H3K27M-targeted vaccine in adults with diffuse midline glioma
published
| article-journal
doi:10.1038/s41591-023-02555-6
|
|
2023-10-31
|
Therapie und Verlauf neurologischer Erkrankungen
unknown status
| book
doi:10.17433/978-3-17-039967-9
|
|
2024-01-01
|
Deep Learning–based Identification of Brain MRI Sequences Using a Model Trained on Large Multicentric Study Cohorts
published
| article-journal
doi:10.1148/ryai.230095
|
|
2023-09-29
|
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
published
| article-journal
doi:10.1200/jco.23.01059
|
|
2023-12-11
|
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: prospective phase 2 MARCIE trial
published
| article-journal
doi:10.1093/neuonc/noad244
|
|
2023-12-28
|
Cluster-based prognostication in glioblastoma: Unveiling heterogeneity based on diffusion and perfusion similarities
published
| article-journal
doi:10.1093/neuonc/noad259
|
|
2024-01-31
|
Cerebrospinal fluid cfDNA sequencing for classification of central nervous system glioma
published
| article-journal
doi:10.1158/1078-0432.ccr-23-2907
|
|
2024-07-26
|
Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
published
| article-journal
doi:10.1158/2767-9764.crc-24-0024
|
|
2024-08-21
|
Figure 4 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797544.v1
|
|
2024-08-21
|
Figure 3 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797547.v1
|
|
2024-08-21
|
Supplementary Figure S1 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797538.v1
|
|
2024-08-21
|
Supplementary Table S1 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797526.v1
|
|
2024-08-21
|
Figure 2 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797550.v1
|
|
2024-08-21
|
Supplementary Figure S2 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797535.v1
|
|
2024-08-21
|
Supplementary Table S3 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797520.v1
|
|
2024-08-21
|
Supplementary Table S4 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797517.v1
|
|
2023-02-11
|
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
published
| article-journal
doi:10.1038/s41467-023-36321-6
|
|
2023-02-21
|
Assessing the added value of ADC, CBV and radiomic MR features for differentiation of pseudoprogression vs. true tumor progression in patients with glioblastoma
published
| article-journal
doi:10.1093/noajnl/vdad016
|
|
2023-07-24
|
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
published
| article-journal
doi:10.1038/s41591-023-02464-8
|
|
2023-08-15
|
Deep-learning based detection of vessel occlusions on CT-angiography in patients with suspected acute ischemic stroke
published
| article-journal
doi:10.1038/s41467-023-40564-8
|
|
2023-06-02
|
Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline
published
| article-journal
doi:10.1093/neuonc/noad100
|
|
2017-12-13
|
Therapie und Verlauf neurologischer Erkrankungen
unknown status
| book
doi:10.17433/978-3-17-031613-3
|
|
2023-12-18
|
Concurrent gliomas in patients with multiple sclerosis
published
| article-journal
doi:10.1038/s43856-023-00381-y
|
|
2023-01-18
|
Clinical outcome following surgical resection and radiotherapy in adult patients with pleomorphic xanthoastrocytoma as defined by DNA methylation profiling
published
| article-journal
doi:10.1093/nop/npad004
|
|
2024-02-06
|
A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1
published
| article-journal
doi:10.1038/s41467-024-45067-8
|
|
2024-03-22
|
Advancing non-invasive glioma classification with diffusion radiomics: Exploring the impact of signal intensity normalization
published
| article-journal
doi:10.1093/noajnl/vdae043
|
|
2024
|
Targeted agents in patients with progressive glioblastoma—A systematic meta‐analysis of randomized clinical trials
published
| article-journal
| CC-BY
doi:10.1002/cam4.7362
|
|
2024-06-24
|
No benefit from TMZ treatment in GB with truly unmethylated <i>MGMT</i> promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly GB patients
published
| article-journal
doi:10.1093/neuonc/noae108
|
|
2024-07-25
|
Whole-Brain Vascular Architecture Mapping Identifies Region-Specific Microvascular Profiles in Vivo
published
| article-journal
doi:10.3174/ajnr.a8344
|
|
2024-08-02
|
"I didn't even wonder why I was on the floor" – mixed methods exploration of stroke awareness and help-seeking behaviour at stroke symptom onset
published
| article-journal
| CC-BY
doi:10.1186/s12913-024-11276-6
|
|
2024-08-21
|
Supplementary Figure S1 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797538
|
|
2024-08-21
|
Data from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.c.7412474
|
|
2024-08-21
|
Supplementary Table S4 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797517
|
|
2024-08-21
|
Figure 1 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797553
|
|
2024-08-21
|
Figure 5 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797541.v1
|
|
2024-08-21
|
Supplementary Figure S2 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797535
|
|
2024-08-21
|
Figure 4 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797544
|
|
2024-08-21
|
Figure 3 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797547
|
|
2024-08-21
|
Supplementary Table S3 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797520
|
|
2024-09-25
|
Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 study
published
| article-journal
doi:10.1093/nop/npae091
|
|
2025-01-22
|
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant
published
| article-journal
doi:10.1093/neuonc/noaf015
|
|
2022-10-12
|
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
published
| article-journal
doi:10.1093/neuonc/noac207
|
|
2023-01-26
|
Author Correction: Federated learning enables big data for rare cancer boundary detection
published
| article-journal
| CC-BY
doi:10.1038/s41467-023-36188-7
|
|
2022-08-02
|
AI-based decision support improves reproducibility of tumor response assessment in neuro-oncology: an international multi-reader study
published
| article-journal
doi:10.1093/neuonc/noac189
|
|
2023-07-26
|
Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas
published
| article-journal
doi:10.1007/s00401-023-02613-w
|
|
2023-01-19
|
Active remodeling of capillary endothelium via cancer cell-derived MMP9 promotes metastatic brain colonization
published
| article-journal
doi:10.1158/0008-5472.can-22-3964
|
|
2023-12-08
|
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression
published
| article-journal
doi:10.1093/neuonc/noad109
|
|
2024
|
Whole-Brain Intracellular pH Mapping of Gliomas Using High-Resolution 31P MR Spectroscopic Imaging at 7.0 T
published
| article-journal
doi:10.1148/rycan.220127
|
|
2024-03-21
|
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling
unknown status
| post
| CC-BY
doi:10.21203/rs.3.rs-3996609/v1
|
|
2024-06-03
|
Incorporating Supramaximal Resection into Survival Stratification of IDH-Wildtype Glioblastoma: A Refined Multi-institutional Recursive Partitioning Analysis
published
| article-journal
doi:10.1158/1078-0432.ccr-23-3845
|
|
2024-06-28
|
Unraveling Glioblastoma Diversity: Insights into Methylation Subtypes and Spatial Relationships
published
| article-journal
doi:10.1093/noajnl/vdae112
|
|
2023-10-12
|
Evaluation of risdiplam efficacy in 5q spinal muscular atrophy: A systematic comparison of electrophysiologic with clinical outcome measures
published
| article-journal
doi:10.1111/ene.16099
|
|
2024-08-21
|
Figure 1 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797553.v1
|
|
2024-08-21
|
Supplementary Table S2 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797523.v1
|
|
2024-08-21
|
Supplementary Table S2 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797523
|
|
2024-08-21
|
Supplementary Figure S4 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797529.v1
|
|
2024-08-21
|
Figure 2 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797550
|
|
2024-08-21
|
Supplementary Figure S4 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797529
|
|
2024-08-21
|
Figure 5 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797541
|
|
2024-08-21
|
Supplementary Figure S3 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797532.v1
|
|
2024-08-21
|
Supplementary Table S1 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797526
|
|
2024-11-22
|
Distinct epigenetic and transcriptional profiles of Epstein-Barr virus (EBV) positive and negative primary CNS lymphomas
published
| article-journal
doi:10.1093/neuonc/noae251
|
|
2025-01-13
|
Cancer Neuroscience of Brain Tumors: From Multicellular Networks to Neuroscience-Instructed Cancer Therapies
published
| article-journal
doi:10.1158/2159-8290.cd-24-0194
|
|
2025-02-01
|
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen
published
| article-journal
| CC-BY
doi:10.1038/s41467-025-56547-w
|
|
2025-01-29
|
Spatially resolved transcriptomics and graph-based deep learning improve accuracy of routine CNS tumor diagnostics
published
| article-journal
doi:10.1038/s43018-024-00904-z
|
|
2024-11-12
|
The prognostic impact of <i>CDKN2A/B</i> hemizygous deletions in IDH-mutant glioma
published
| article-journal
doi:10.1093/neuonc/noae238
|
|
2024-08-21
|
Data from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.c.7412474.v1
|
|
2024-08-21
|
Supplementary Figure S3 from Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases
unknown status
| post
| CC-BY
doi:10.1158/2767-9764.26797532
|
|
2024-09-21
|
Analysis of safety and efficacy of proton radiotherapy for optic nerve sheath meningioma (ONSM)
published
| article-journal
doi:10.1093/noajnl/vdae160
|
|
2025-01-13
|
AI-based histopathological classification of central nervous system tumours
unknown status
| post
| CC-BY
doi:10.21203/rs.3.rs-5600492/v1
|
|
2024-11-19
|
Treatment of glioblastoma patients with personalized vaccines outside clinical trials: Lessons ignored?
published
| article-journal
doi:10.1093/neuonc/noae225
|
|
2024-08-09
|
Transgenic T cell therapy targeting the glioblastoma stem cell antigen PTPRZ1 with a vaccine-induced, patient-derived T cell receptor
unknown status
| post
| CC-BY
doi:10.21203/rs.3.rs-4782908/v1
|
|
2025
|
Arterial Collaterals and Endovascular Treatment Effect in Acute Ischemic Stroke with Large Infarct: A Secondary Analysis of the TENSION Trial
published
| article-journal
doi:10.1148/radiol.242401
|
|
2024-10-16
|
Addressing the Generalizability of AI in Radiology Using a Novel Data Augmentation Framework with Synthetic Patient Image Data: Proof-of-Concept and External Validation Classification Tasks in Multiple Sclerosis
published
| article-journal
doi:10.1148/ryai.230514
|
|
2025
|
High-Resolution US vs MR Neurography for Diagnosis of Upper Extremity Peripheral Nerve Disorders
published
| article-journal
doi:10.1148/radiol.232063
|
|
2025-03-14
|
Long-term CSF responses in adult patients with spinal muscular atrophy type 2 or 3 on treatment with nusinersen
published
| article-journal
doi:10.1007/s00415-025-12984-7
|